Post-Pandemic New Normal: China’s IVD Market Opportunities

The demand for IVD product due to the Covid-19 pandemic is expected to increase mainly due to factors as a sharp rise in market demand for PCR, NGS products, the supportive regulatory landscape for product development & commercialization, and a sharp rise in target patient population. The Chinese market is expected to reach almost 200 billion USD